Seelos Therapeutics, Inc. (SEELQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Seelos Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -460.1% |
| December 31, 2023 | -835.1% |
| September 30, 2023 | |
| June 30, 2023 | -8.78K% |
| March 31, 2023 | -1.66K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -858.9% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -88.70% |
| September 30, 2015 | -395.4% |
| June 30, 2015 | -1.14K% |
| March 31, 2015 | -1.35K% |
| December 31, 2014 | -906.6% |
| September 30, 2014 | -165.0% |
| June 30, 2014 | 22.09% |
| March 31, 2014 | |
| December 31, 2013 | -451.7% |
| September 30, 2013 | -11.42K% |
| June 30, 2013 | -342.8% |
| March 31, 2013 | -681.7% |
| September 30, 2012 | -48.41% |
| June 30, 2012 | -4.12K% |
| March 31, 2012 | -603.1% |
| December 31, 2011 | -3.93K% |
| September 30, 2011 | -277.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | -43.31K% |